The Market LogEnter at least 2 characters. Company and ticker searches are not case-sensitive.

Company profile

CNS Pharmaceuticals, Inc. insider acquisitions

Company CIK 0001729427 · Reported insider acquisitions and filing context.

Company filings at SEC ↗
CNSP · Nasdaq

These are company listings. A transaction is linked to a particular security only when the filing provides enough information.

Company activity summary

By transaction date, as of October 23, 2026.

7 days30 days90 daysOverlapping periods · securities and currencies kept separate

No records are loaded for this 30-day transaction window. This does not establish that no transactions occurred.

Known purchase value sums available amounts for non-derivative purchases only. Missing amounts are excluded. “Currency not specified” does not establish that the amounts share a currency. These summaries use all matching loaded records, while the timeline below covers only the current page.

Transaction timeline

Who reported an acquisition, and when the transaction occurred.

Reported acquisitions by transaction dateEach row is a reporting owner. Select a marker to open its transaction details. Jointly reported transactions appear for each associated reporting owner, without dividing quantities or amounts.Levin RamiLevin RamiKeyes Jeffry R.Keyes Jeffry R.Cockroft Bettina M.Cockroft Bettina M.Mahery AmyMahery AmyClimaco John MClimaco John MCharles Faith L.Charles Faith L.Downs ChristopherDowns ChristopherGumulka JerzyGumulka JerzyLevin Rami · January 1, 2026 · Stock award · Restricted Stock UnitsKeyes Jeffry R. · November 17, 2025 · Stock award · Option to purchase common stockCockroft Bettina M. · November 17, 2025 · Stock award · Option to purchase common stockMahery Amy · November 17, 2025 · Stock award · Option to purchase common stockClimaco John M · November 17, 2025 · Stock award · Option to purchase common stockCharles Faith L. · November 17, 2025 · Stock award · Option to purchase common stockDowns Christopher · November 17, 2025 · Stock award · Option to purchase common stockGumulka Jerzy · November 17, 2025 · Stock award · Option to purchase common stockNov 17, 2025Jan 1, 2026
PurchaseStock awardGift receivedExercise / conversionConversionOther acquisition

8 dated transactions · 8 of 8 reporting owners shown. Select one owner to focus the chart.

View timeline as a table
Transaction dateCompany / securityReporting ownersAcquisition type
Jan 1, 2026CNS Pharmaceuticals, Inc.Restricted Stock UnitsLevin RamiStock award
Nov 17, 2025CNS Pharmaceuticals, Inc.Option to purchase common stockKeyes Jeffry R.Stock award
Nov 17, 2025CNS Pharmaceuticals, Inc.Option to purchase common stockCockroft Bettina M.Stock award
Nov 17, 2025CNS Pharmaceuticals, Inc.Option to purchase common stockMahery AmyStock award
Nov 17, 2025CNS Pharmaceuticals, Inc.Option to purchase common stockClimaco John MStock award
Nov 17, 2025CNS Pharmaceuticals, Inc.Option to purchase common stockCharles Faith L.Stock award
Nov 17, 2025CNS Pharmaceuticals, Inc.Option to purchase common stockDowns ChristopherStock award
Nov 17, 2025CNS Pharmaceuticals, Inc.Option to purchase common stockGumulka JerzyStock award

Only transactions on this page are shown. Date windows end on the latest transaction date in this sample. Joint filings may appear on more than one row. Sales are not included. Share-price charts use a separate data source.

Share price & reported acquisitions

Daily closing prices from a separate source. The date window above also filters prices; reporting-owner and transaction-type selections filter the markers.

Price history is not available

Market-price history is not connected yet.

CNSP · Currency not specified. A marker uses that day's closing price, not the reported transaction price. No price is substituted for a missing trading day.

Reported acquisitions

Filing-date filters apply to the list and timeline. The summary above uses transaction dates.

Reset
Reported insider acquisitions, ordered by filing date, newest first. Currency is shown only when reported.
Filed / transactedReporting ownersType / securityQuantityPrice / reference valueDetails
Trade:
Levin RamiCEO and President · Director
Stock awardRestricted Stock UnitsDerivative security · Code A19,000Not reported *Value: Not reportedCurrency not specifiedView ↗
Trade: Stock awardOption to purchase common stockDerivative security · Code A1,5170 *Value: 0Currency not specifiedView ↗
Trade: Stock awardOption to purchase common stockDerivative security · Code A1,5170 *Value: 0Currency not specifiedView ↗
Trade:
Mahery AmyDirector
Stock awardOption to purchase common stockDerivative security · Code A1,5170 *Value: 0Currency not specifiedView ↗
Trade:
Climaco John MChief Executive Officer · Director
Stock awardOption to purchase common stockDerivative security · Code A9,7610 *Value: 0Currency not specifiedView ↗
Trade: Stock awardOption to purchase common stockDerivative security · Code A1,5170 *Value: 0Currency not specifiedView ↗
Trade:
Downs ChristopherChief Financial Officer
Stock awardOption to purchase common stockDerivative security · Code A4,8810 *Value: 0Currency not specifiedView ↗
Trade: Stock awardOption to purchase common stockDerivative security · Code A1,5170 *Value: 0Currency not specifiedView ↗

Reporting owners are associated with a filing. Jointly reported amounts are not allocated to individual owners. Historical coverage is still being built. Read the methodology →